Call for Tracks

Track 2: Cutting edge pharmaceutical and analytical applications of newly developed materials

Organizers

Track Chair:

Dr. Ahmed Sayed Saad, Faculty of Pharmacy, Egypt-Japan University of Science and Technology (E-JUST), Associate Professor of Pharmaceutical Analytical Chemistry.

Co-Chairs:

  • Dr. Amr Mohamed Mahmoud, Faculty of Pharmacy, Cairo University, Professor of Pharmaceutical Analytical Chemistry.
  • Dr. Mennatallah Ali, Faculty of Pharmacy, Egypt-Japan University of Science and Technology (E-JUST), Associate Professor of Pharmacology and Toxicology.
  • Dr. Mona Magdy Saber, Faculty of Pharmacy, Egypt-Japan University of Science and Technology (E-JUST), Associate Professor of Clinical Pharmacy.

Abstract of the track

Background: Recent advances in material science have reshaped pharmaceutical and analytical chemistry, enabling unprecedented sensitivity, selectivity, and therapeutic performance. Newly developed materials—particularly at the nanoscale—have opened new horizons for drug analysis, toxicological assessment, targeted delivery, and tissue regeneration. These innovations bridge fundamental chemistry with real-world clinical and analytical applications.
Subject: This track focuses on the design, characterization, and application of newly developed materials in pharmaceutical analysis and biomedical research. Emphasis is placed on nanomaterials (e.g., nanoparticles, nanocomposites, and hybrid nanostructures), engineered biomolecules in therapeutics and biosensors, and novel drug systems that enhance analytical performance and therapeutic outcomes, including wound healing and regenerative medicine.
Research hotpot:
  • Nanomaterials for sensitive and selective drug and toxin analysis.
  • Nanomaterials with therapeutic effects, including antimicrobial and wound-healing activity.
  • Nanocomposites as multifunctional platforms for sensing, targeting and therapy.
  • Nano-enabled analytical techniques (electrochemical, spectroscopic, and biosensing approaches).
  • Newly engineered drugs and biomolecules with improved bioavailability and targeting.
  • Translation of nanomaterials from analytical laboratories to clinical and pharmaceutical use.

Topics

  • Analytical and bioanalytical applications of nanomaterials.
  • Nanomaterials in drug quality control and toxic compound detection.
  • Nano-based sensors and smart analytical platforms.
  • Novel nanocomposites for diagnostic and therapeutic functions.
  • Engineered drugs, biomolecules, and delivery systems.
  • Biomedical applications of nanomaterials, such as antimicrobial, wound healing and tissue repair.

Recommended Invited Speaker

1. Mahmoud Rabah
2. Dr. Amr Abdelmotagally Nasrallah
3. Dr. Mennatallah Ali